http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2362242-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 |
filingDate | 2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9806ad9df4f174e77b7ffec0f63b6adb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1ffa95fe77f438ccc23fcc83ee6a0bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033e0f9d648015d3d4271760c3a34173 |
publicationDate | 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2362242-T3 |
titleOfInvention | CONTRACEPTIVE. |
abstract | Pharmaceutical form for hormonal contraception consisting of a certain amount of daily units containing hormones, which presents a combination of hormones consisting of at least one estrogen selected from the group consisting of ethinyl estradiol (I) and estradiol (II), as components estrogens, and at least one chlormadinone acetate metabolite selected from the group that includes 3α-hydroxy-6-chloro-17α-acetoxy 4,6-pregnadien-20-one (3α-hydroxychlormadinone acetate), 3β-hydroxy- 6-Chloro-17α-acetoxy-4,6-pregnadien-20-one (3β-hydroxychlormadinone acetate), if appropriate mixed with chlormadinone acetate and / or 3α-hydroxy-17α-acetoxy 5β-pregnan-20-one and / or 3β-hydroxy-17α-acetoxy-5β-pregnan-20-one, as gestagenic components, for the uninterrupted daily oral administration of daily units containing hormones, if necessary in combination with 7 to 3 daily units without hormones . |
priorityDate | 2006-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.